Cytogenetics of hematologic neoplasms

The Principles of Clinical Cytogenetics

Volumn , Issue , 2005, Pages 365-420

  Naeem, Rizwan C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745247408     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1385/1-59259-833-1:365     Document Type: Chapter

References (282)

1. Harris, N. L., Jaffe, E. S., Diebold, J., et al. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J. Clin. Oncol. 17, 3835-3849.
2. Tjio, J. H. and Levan, H. (1956) The chromosome number of man. Hereditas 42, 1-6.
3. Nowell, P. C. (1960) Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 20, 462-466.
4. Nowell, P. C. and Hungerford, D. A. (1960) A minute chromosome in human granulocytic leukemia. Science 132, 1497.
5. Rowley, J. D. (1999) The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36(4) (Suppl. 7), 59-72.
6. Nowell, P. C., Rowley, J. D., and Knudson, A. G., Jr. (1998) Cancer genetics, cytogenetics-defining the enemy within. Nature Med. 4, 1107-1111.
7. Jaffe, E. S., Harris, N. L., Stein, H., and Vardiman, J. W. (eds.) (2001) The World Health Organization Classification in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 3rd ed., Inernational Agency for Research on Cancer (IARC) Press, Lyon, France.
8. Faderl, S., Talpaz, M., Estrov, Z., and Kantarjian, H. M. (1999) Chronic myelogenous leukemia: biology and therapy. Ann. Intern. Med. 131, 207-219.
9. Young, J. L., Jr., Percy, C. L., Asire, A. J., et al. (1977) Cancer Incidence and Mortality in the United States, 1973-77. National Cancer Institute Monograph.
10. Gunz, F. W. (1977) The epidemiology and genetics of the chronic leukaemias. Clin. Haematol. 6, 3-20.
11. Savage, D. G., Szydlo, R. M., and Goldman, J. M. (1997) Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br. J. Haematol. 96, 111-116.
12. Rowley, J. D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293.
13. Bartram, C R., De Klein, A., Hagemeijer, A., et al. (1983) Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306(5940), 277-280.
14. Melo, J. V. (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88, 2375-2384.
15. Pane, F., Frigeri, F., Sindona, M., et al. (1996) Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 88, 2410-2414.
16. Saglio, G., Pane, F., Gottardi, E., et al. (1996) Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87, 1075-1080.
17. Mitelman, F. (1993). The cytogenetic scenario of chronic myeloid leukemia. Leukocyte Lymphoma. 11(Suppl. 1), 11-15.
18. Gordon, M. Y. and Goldman, J. M. (1996) Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. Br. J. Haematol. 95, 10-20.
19. Lee, D. S., Lee, Y.-S., Yun, Y.-S., et al. (2003) A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Genes Chromosomes Cancer 37, 291-299.
20. Rumpel, M., Friedrich, T., and Deninger, M. W. N. (2003) Imatinib normalizes bone marrow vascularity in patients with chronic myeloid leukemia in first chronic phase. Blood 101(11), 4641-4643.
21. Deeg, H. J., Storb, R., Thomas, E. D., et al. (1985) Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65, 1325-1335.
22. Druker, B. J. and Lydon, N. B. (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J. Clin. Invest. 105, 3-7.
23. Mortazavi, Y., Tooze, J. A., Gordon-Smith, E. C., and Rutherford, T. R. (2000) N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/paroxysmal nocturnal hemoglobinuria during evolution to clonal disease. Blood 95, 646-650.
24. Froberg, M. K. and Brunning, R. D. (1998) Demonstration of clonality in in neutrophils using FISH in a case of chronic neutrophilic leukemia. Leukemia 12, 623-626.
25. Yanagisawa, K., Ohminami, H., Sato, M., et al. (1998) Neoplastic involvement of granulocytic lineage, not granulocytic-monocytic, monocytic, or erythrocytic lineage, in a ptient with chronic neurophilic leukemia. Am. J. Hematol. 57, 221-224.
26. Di Donato, C., Croci, G., Lazzari, S., Scarduelli, L., Vignoli, R., Buia, M., Tramaloni, C., Maccari, S., and Plancher, A. C. (1986) Chronic neutrophilic leukemia: description of a new case with karyotypic abnormalities. Am. J. Clin. Pathol. 85, 369-371.
27. Matano, S., Nakamura, S., Kobayashi, K., Yoshida, T., Matsuda, T., and Sugimoto, T. (1997) Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association. Am. J. Hematol. 54, 72-75.
28. Berkowicz, M., Rosner, E., Rechavi, G., et al. (1991) Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association. Cancer Genet. and Cytogenet. 51, 277-278.
29. Golub, T. R., Barker, G. F., Lovett, M., and Gilliland, D. G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t (5;12) chromosomal translocation. Cell 77, 307-316.
30. Baranger, L., Szapiro, N., Gardais, J., et al. (1994) Translocation t (5;12) (q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia. Br. J. Haematol. 88(2), 343-347.
31. Dewald, G. W. and Wright, P. I. (1995) Chromosome abnormalities in the myeloproliferative disorders. Semin. Oncol. 22, 341-354.
32. Rege-Cambrin, G., Mecucci, C., Tricot, G., et al. (1987) A chromosomal profile of polycythemia vera. Cancer Genet. and Cytogenet. 25, 233-245.
33. Swolin, B., Weinfeld, A., and Westin, J. (1988) A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 72, 386-395.
34. Dupriez, B., Morel, P., Demory, J. L., et al. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 88, 1013-1018.
35. Reilly, J. T., Snowden, J. A., Spearing, R. L., et al. (1997) Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br. J. Haematol. 98, 96-102.
36. Anon. (1981) Report on essential thrombocythemia. Cancer Genet. and Cytogenet. 4, 138-142.
37. Sessarego, M., Defferrari, R., Dejana, A. M., et al. (1989) Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation: a 12-year study. Cancer Genet. and Cytogenet. 43, 57-65.
38. Cogswell, P. C., Morgan, R., Dunn, M., et al. (1989) Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia. Blood 74, 2629-2633.
39. Skinnider, B. F., Elia, A. J., Gascoyne, R. D., et al. (2001) Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 97, 250-255.
40. Fenaux, P., Chomienne, C., and Degos, L. (1987) Acute promyelocytic leukemia: biology and treatment. Semin. Oncol. 24, 92-102.
41. Anon. (1991) Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospecitive multicenter study of 100 patients. Cancer Genet. and Cytogenet. 55, 57-65.
42. Storniolo, A. M., Moloney, W. C., Rosenthal, D. S., Cox, C., and Bennett, J. M. (1990). Chronic myelomonocytic leukemia. Leukemia 4, 766-770.
43. Germing, U., Gattermann, N., Minning, H., Heyll, A., and Aul, C. (1998) Problems in the classification of CMML-dysplastic versus proliferative type. Leukemia Res. 22, 871-878.
44. Misawa, S., Horiike, S., Kaneko, H., et al. (1998) Significance of chromosomal alterations and mutations of the N-RAS and TP53 genes in relation to leukemogenesis of acute myeloid leukemia. Leukemia Res. 22, 631-637.
45. Shepherd, P. C., Ganesan, T. S., and Galton, D. A. (1987) Haematological classification of the chronic myeloid leukaemias. Baillieres Clin. Haematol. 1, 887-906.
46. Hernáandez, J. M., Del Caänizo, M. C., Cuneo, A., et al. (2000) Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann. Oncol. 11, 441-444.
47. Martiat, P., Michaux, J. L., and Rodhain, J. (1991) Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. Groupe Français de Cytogénétique Háematologique. Blood 78, 205-211.
48. Shukralla, N., Finiewicz, K., Roulston, D., et al. (1997) Is atypical chronic myeloid leukemia a high white count myelodysplastic disorder? Mod. Pathol. 10, 134a.
49. Siena, S., Sammarelli, G., Grimoldi, M. G., et al. (1999) New reciprocal translocation t (5;10) (q33;q22) associated with atypical chronic myeloid leukemia. Haematologica 84, 369-372.
50. Kulkarni, S., Heath, C., Parker, S., et al. (2000) Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t (5;10) (q33;q21). Cancer Res. 60, 3592-3598.
51. Amenomori, T., Tomonaga, M., Yoshida, Y., et al. (1986) Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvenile chronic myeloid leukaemia: both granulocyte-macrophage precursors and erythroid precursors carry identical marker chromosome. Br. J. Haematol. 64, 539-546.
52. Busque, L., Gilliland, D. G., Prchal, J. T., et al. (1995) Clonality in juvenile chronic myelogenous leukemia. Blood 85, 21-30.
53. Miles, D. K., Freedman, M. H., Stephens, K., et al. (1996) Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood 88, 4314-4320.
54. Hasle, H. (1994) Myelodysplastic syndromes in childhood-classification, epidemiology, and treatment. Leukemia Lymphoma 13, 11-26.
55. Arico, M., Biondi, A., and Pui, C. H. (1997) Juvenile myelomonocytic leukemia. Blood. 90, 479-488.
56. Luna-Fineman, S., Shannon, K. M., Atwater, S. K., et al. (1999) Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 93, 459-466.
57. Castro-Malaspina, H., Schaison, G., Passe, S., et al. (1984) Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer 54, 675-686.
58. Suda, T., Miura, Y., Mizoguchi, H., et al. (1982) Characterization of hemopoietic precursor cells in juvenile-type chronic myelocytic leukemia. Leukemia Res. 6, 43-53.
59. Hess, J. L., Zutter, M. M., Castleberry, R. P., and Emanuel, P. D. (1996) Juvenile chronic myelogenous leukemia. Am. J. Clin. Pathol. 105, 238-248.
60. Side, L. E., Emanuel, P. D., Taylor, B., et al. (1998) Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92, 267-272.
61. Flotho, C., Valcamonica, S., Mach-Pascual, S., et al. (1999) RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 13, 32-37.
62. Brunning, R. D., Bennett, J. M., Flandrin, G., et al. (2001) Myelodysplastic syndromes: Introduction. In The World Health Organization Classification in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 3rd ed. (Jaffe, E. S., Harris, N. L., Stein, H., and Vardiman, J. W., eds.), Inernational Agency for Research on Cancer (IARC) Press, Lyon, France, pp. 61-73.
63. Willman, C. L. (1998) Molecular genetic features of myelodysplastic syndrome (MDS). Leukemia 12(Suppl. 1), S2-S6.
64. Mathew, P., Tefferi, A., Dewald, G. W., et al. (1993) The 5q-syndrome: a single-institution study of 43 consecutive patients. Blood 81, 1040-1045.
65. Caligiuri, M. A., Strout, M. P., and Gilliland, D. G. (1997) Molecular biology of acute myeloid leukemia. Semin. Oncol. 24, 32-44.
66. Downing, J. R. (1999) Molecular genetics of acute myeloid leukemia. In Childhood Leukemias. Cambridge University Press, New York.
67. Albitar, M. and Freireich, E. J. (2000) Molecular defects in chronic myeloproliferative disorders. Mol. Med. 6, 555-567.
68. Baer, M. R., Stewart, C. C., Davey, F. R., Schiffer, C. A., and Bloomfield, C. C. (1998) Expression of the neural cell adhesion molecule CD56 is associate with short remission duration and survival in acute myeloid leukemia with t (8:21) (q22;q22). Blood 90, 1643-1648.
69. Rege, K., Swansburg, G. L., Atra, A. A., et al. (2000) Influence of age, secondary karyotype abnormalities CD19 status and extramedullary leukemia on survival. Leukemia Lymphoma 40, 67-77.
70. Schoch, C., Haase, D., Haferlach, T., et al. (1996) Fifty-one patients with acute myeloid leukemia and translocation t (8;21) (q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 10, 1288-1295.
71. Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., and Rowley, J. D. (1983) Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogentic-clinicopathological association. N. Engl. J. Med. 309, 630-636.
72. Marlton, P., Keathing, M., Kantarjian, H., et al. (1995) Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9, 965-971.
73. Grimwade, D., Walker, H., Oliver, F., et al. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. Blood 92, 2322-2333.
74. Stanley, M., McKenna, R. W., Ellinger, G., and Brunning, R. D. (1985) Classification of 358 Cases of Acute Myeloid Leukemia by FAB Criteria: Analysis of Clinical and Morphologic Findings in Chronic and Acute Leukemias, Martin Nijhoff, Boston.
75. De The, H., Chomienne, C., Lanotte, M., Degos, L., and Dejean, A. (1990) The t (15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558-561.
76. Melnick, A. and Licht, J. D. (1999) Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
77. Castaigne, S., Chomienne, C., Daniel, M. T., et al. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Blood 76, 1704-1709.
78. Tallman, M. S., Andersen, J. W., Schiffer, C. A., et al. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. N. Engl. J. Med. 337, 1021-1028.
79. Fenaux, P., Jouet, J. P., Zandecki, M., et al. (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br. J. Haematol. 65, 101-106.
80. Chen, S. J., Zelent, A., Tong, J. H., et al. (1993) Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t (11;17) (q23;q21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91, 2260-2267.
81. Sainty, D., Liso, V., Cantáu-Rajnoldi, A., et al. (2000) A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Group Français de Cytogáenáetique Háematologique, UK Cancer Cytogenetics Group and BIOMED 1 European Coomunity-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies." Blood 96, 1287-1296.
82. Gahn, B., Haase, D., Unterhalt, M., et al. (1996) De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance. Leukemia 10, 946-951.
83. Mrozek, K., Heinonen, K., De La Chapelle, A., and Bloomfield, C. D. (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Semin. Oncol. 24, 17-31.
84. Leith, C. P., Kopecky, K. J., Godwin, J., et al. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood 89, 3323-3329.
85. Leith, C. P., Kopecky, K. J., Chen, I. M., et al. (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 94, 1086-1099.
86. Head, D. R. (1996) Revised classification of acute myeloid leukemia. Leukemia 10, 1826-1831.
87. Ellis, M., Ravid, M., and Lishner, M. (1993) A comparative analysis of alkylating agent and epipodophyllotoxinrelated leukemias. Leukemia Lymphoma 11, 9-13.
88. Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., et al. (1993) Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. 7, 1975-1986.
89. Pui, C. H., Relling, M. V., Rivera, G. K., et al. (1995) Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 9, 1990-1996.
90. Quesnel, B., Kantarjian, H., Bjergaard, J. P., et al. (1993) Therapy-related acute myeloid leukemia with t (8;21), inv (16), and t (8;16): a report on 25 cases and review of the literature. J. Clin. Oncol. 11, 2370-2379.
91. Secker-Walker, L. M., Moorman, A. V., Bain, B. J., and Mehta, A. B. (1998) Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. Leukemia 12, 840-844.
92. Michels, S. D., McKenna, R. W., Arthur, D. C., and Brunning, R. D. (1985) Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 65, 1364-1372.
93. Venditti, A., Del Poeta, G., Stasi, R., et al. (1994) Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br. J. Haematol. 88, 784-793.
94. Stark, B., Resnitzky, P., Jeison, M., et al. (1995) A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t (8:16) (p11:p13), in a patient with the variant t (8:19) (p11:q13)-case report and review of the literature. Leukemia Res. 19, 367-379.
95. Bernstein, J., Dastugue, N., Haas, O. A., et al. (2000) Nineteen cases of the t (1;22) (p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t (1;22) study group. Leukemia 14, 216-218.
96. Murphy, S. B. (1978) Childhood non-Hodgkin's lymphoma. N. Engl. J. Med. 299, 1446-1448.
97. Ries, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., and Edwards, B. K. (1999). SEER Cancer Statistics Review, 1973-1996, National Cancer Institute.
98. Sandler, D. P. and Ross, J. A. (1997) Epidemiology of acute leukemia in children and adults. Semin. Oncol. 24, 3-16.
99. Ries, L. A. G., Smith, M. A., Gurney, J. G., et al. (1995) Cancer incidence and survival among children and adolescents. SEER Program 1975-1995, National Cancer Institute.
100. Navid, F., Mosijczuk, A. D., Head, D. R., et al. (1999) Acute lymphoblastic leukemia with the (8;14) (q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia 13, 135-141.
101. Raimondi, S. C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81, 2237-2251.
102. Martin, P. L., Look, A. T., Schnell, S., et al. (1996) Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study. J. Pediatr. Hematol. Oncol. 18, 113-121.
103. Lange, B. J. (2000) The ultra low risk child with acute lymphoblastic leukemia. In Education Program Book. American Society of Hematology, Washington, DC, pp. 286-294.
104. Pilozzi, E., Muller-Hermelink, H. K., Falini, B., et al. (1999) Gene rearrangements in T-cell lymphoblastic lymphoma. J. Pathol. 188, 267-270.
105. Okuda, T., Fisher, R., and Dwoning, J. R. (1996) Molecular diagnositcs in pediatric acute lymphoblastic leukemia. Mol. Diagn. 1, 139-151.
106. Schneider, N. R., Carroll, A. J., Shuster, J. J., et al. (2000) New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases. Blood 96, 2543-2549.
107. Anon. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89, 3909-3918.
108. Armitage, J. O. and Weisenburger, D. D. (1998) New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J. Clin. Oncol. 16, 2780-2795.
109. Prevot, S., Hamilton-Dutoit, S., Audouin, J., Walter, P., Pallesen, G., and Diebold, J. (1992) Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization. Br. J. Haematol. 80, 27-32.
110. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N., and Pasternack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46, 219-234.
111. Bizzozero, O. J., Jr., Johnson, K. G., and Ciocco, A. (1966) Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time. N. Engl. J. Med. 274, 1095-1101.
112. Ben-Ezra, J., Burke, J. S., Swartz, W. G., et al. (1989) Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 73, 579-587.
113. Lennert, K. (1978) Malignant Lymphomas Other Than Hodgkin's Disease. Springer-Verlag, New York.
114. Damle, R. N., Wasil, T., Fais, F., et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840-1847.
115. Dèohner, H., Stilgenbauer, S., Dèohner, K., Bentz, M., and Lichter, P. (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J. Mol. Med. (Berlin) 77, 266-281.
116. Dèohner, H., Stilgenbauer, S., Fischer, K., Bentz, M., and Lichter, P. (1997) Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 11(Suppl. 2), S19-S24.
117. Oscier, D. G., Thompsett, A., Zhu, D., and Stevenson, F. K. (1997) Differential rates of somatic hypermutation in V (H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89, 4153-4160.
118. Dèohner, H., Stilgenbauer, S., James, M. R., et al. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89, 2516-2522.
119. Juliusson G., Oscier D. G., Fitchett, M., et al. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N. Engl. J. Med. 323(11), 720-724.
120. Matutes, E., Oscier, D., Garcia-Marco, J., et al. (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br. J. Haematol. 92, 382-388.
121. Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., and Stevenson, F. K. (1999) Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848-1854.
122. Berger, F., Felman, P., Thieblemont, C., et al. (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95, 1950-1956.
123. Mollejo, M., Menárguez, J., Lloret, E., et al. (1995) Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am. J. Surg. Pathol. 19, 1146-1157.
124. Isaacson, P. G., Matutes, E., Burke, M., and Catovsky, D. (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood 84, 3828-3834.
125. Matutes, E., Morilla, R., Owusu-Ankomah, K., Houlihan, A., and Catovsky, D. (1994) The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B cell disorders. Blood 83, 1558-1562.
126. Zhu, D., Oscier, D. G., and Stevenson, F. K. (1995) Splenic lymphoma with villous lymphocytes involves B-cells with extensively mutated Ig heavy chain variable region genes. Blood 85, 1603-1607.
127. Mateo, M., Mollejo, M., Villuendas, R., et al. (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am. J. Path. 154, 1583-1589.
128. Corcoran, M. M., Mould, S. J., Orchard, J. A., et al. (1999) Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene. 18(46), 6271-6277.
129. Gruszka-Westwood, A. M., Matutes, E., Coignet, L. J., Wotherspoon, A., and Catovsky, D. (1999) The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. Br. J. Haematol. 104, 600-604.
130. Mulligan, S. P., Matutes, E., Dearden, C., and Catovsky, D. (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br. J. Haematol. 78, 206-209.
131. Grogan, T. M. and Spier, C. M. (2001) The B cell immunoproliferative disorders including multiple myeloma and anyloidosis. In Neoplastic Hematopathology. Vol. 2. (Knowles, D. M., ed.), Lippincott Williams and Wilkins, Philadelphia.
132. Barlogie, B., Epstein, J., Selvanayagam, P., and Alexanian, R. (1989) Plasma cell myeloma-new biological insights and advances in therapy. Blood 73, 865-879.
133. Dewald, G. W., Kyle, R. A., Hicks, G. A., and Greipp, P. R. (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66, 380-390.
134. Durie, B. G. (1992) Cellular and molecular genetic features of myeloma and related disorders. Hematol. Oncol. Clin. North Am. 6, 463-477.
135. Sawyer, J. R., Waldron, J. A., Jagnnath, S., and Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet. Cytogenet. 82, 41-49.
136. Lai, J. L., Zandecki, M., Mary, J. Y., et al. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85, 2490-2497.
137. Konigsberg, R., Zojer, N., Ackermann, J., et al. (2000) Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. J. Clin. Oncol. 18, 804-812.
138. Chesi, M., Bergsagel, P. L., Brents, L. A., Smith, C. M., Gerhard, D. S., and Kuehl, W. M. (1996). Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88, 674-681.
139. Vasef, M. A., Medeiros, L. J., Yospur, L. S., Sun, N. C., Mccourty, A., and Brynes, R. K. (1997) Cyclin D1 protein in mutiple myeloma and plasmacytoma: An immunohistochemical study using fixed, paraffin-bembedded tissue sections. Mod. Pathol. 10, 927-932.
140. Mahmoud, M. S., Huang, N., Nobuyoshi, M., Lisukov, I. A., Tanaka, H., and Kawano, M. M. (1996) Altered expression of Pax-5 gene in human myeloma cells. Blood 87, 4311-4315.
141. Dalton, W. S., Grogan, T. M., Meltzer, P. S., et al. (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol. 7, 415-424.
142. Salmon, S. E. and Cassady, J. R. (1988) Plasma cell neoplasms. In Cancer, Principles and Practice of Oncology (DeVita, V. T., Hellman, S., and Rosenberg, S., eds.), Lippincott, Philadelphia.
143. Radaszkiewicz, T., Dragosics, B., and Bauer, P. (1992) Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 102, 1628-1638.
144. Doglioni, C., Wotherspoon, A. C., Moschini, A., De Boni, M., and Isaacson, P. G. (1992) High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339, 834-835.
145. Kato, I., Tajima, K., Suchi, T., et al. (1985) Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn. J. Cancer Res. 76, 1085-1090.
146. Holm, L. E., Blomgren, H., and Lowhagen, T. (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N. Engl. J. Med. 312, 601-604.
147. Hussell, T., Isaacson, P. G., Crabtree, J. E., and Spencer, J. (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342, 571-574.
148. Isaacson, P. G. and Spencer, J. (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11, 445-462.
149. Isaacson, P. G., Wotherspoon, A. C., Diss, T., and Pan, L. X. (1991). Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am. J. Surg. Pathol. 15, 819-828.
150. Du, M., Diss, T. C., Xu, C., Peng, H., Isaacson, P. G., and Pan, L. (1996) Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10, 1190-1197.
151. Wotherspoon, A. C., Finn, T. M., and Isaacson, P. G. (1995) Trisomy 3 in low-grade B-cell lymphomas of mucosaassociated lymphoid tissue. Blood 85, 2000-2004.
152. Brynes, R. K., Almaguer, P. D., Leathery, K. E., et al. (1996) Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod. Pathol. 9, 995-1000.
153. Ott, G., Katzenberger, T., Greiner, A., et al. (1997) The t (11;18) (q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 57, 3944-3948.
154. Dierlamm, J., Baens, M., Wlodarska, I., et al. (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t (11;18) (q21;q21) p6ssociated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601-3609.
155. Cleary, M. L., Meeker, T. C., Levy, S., et al. (1986). Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44, 97-106.
156. Ottensmeier, C. H., Thompsett, A. R., Zhu, D., Wilkins, B. S., Sweetenham, J. W., and Stevenson, F. K. (1998) Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 91, 4292-4299.
157. Tilly, H., Rossi, A., Stamatoullas, A., et al. (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84, 1043-1049.
158. Rowley, J. D. (1988) Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J. Clin. Oncol. 6, 919-925.
159. Horsman, D. E., Gascoyne, R. D., Coupland, R. W., Coldman, A. J., and Adomat, S. A. (1995) Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t (14; 18) in follicular lymphoma. Am. J. Clin. Pathol. 103, 472-478.
160. Lennert, K., Stein, H., and Kaiserling, E. (1975) Cytological and functional criteria for the classification of malignant lymphomata. Br. J. Cancer 31(Suppl. 2), 29-43.
161. Tolksdorf, G., Stein, H., and Lennert, K. (1980) Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br. J. Cancer 41, 168-182.
162. Swerdlow, S. H., Habeshaw, J. A., Murray, L. J., Dhaliwal, H. S., Lister, T. A., and Stansfeld, A. G. (1983) Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am. J. Pathol. 113, 181-197.
163. Argatoff, L. H., Connors, J. M., Klasa, R. J., Horsman, D. E., and Gascoyne, R. D. (1997) Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89, 2067-2078.
164. Schaffner, C., Idler, I., Stilgenbauer, S., Dohner, H., and Lichter, P. (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc. Natl. Acad. Sci. USA 97, 2773-2778.
165. Kumar, S., Krenacs, L., Otsuki, T., et al. (1996) bc1-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am. J. Clin. Pathol. 105, 737-743.
166. Du, M. Q., Diss, T. C., Xu, C. F., Wotherspoon, A. C., Isaacson, P. G., and Pan, L. X. (1997) Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br. J. Haematol. 96, 124-131.
167. Hummel, M., Tamaru, J., Kalvelage, B., and Stein, H. (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84, 403-407.
168. Pittaluga, S., Tierens, A., Pinyol, M., Campo, E., Delabie, J., and De Wolf-Peeters, C. (1998) Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. Br. J. Haematol. 102, 1301-1306.
169. Rosenberg, C. L., Wong, E., Petty, E. M., et al. (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 88, 9638-9642.
170. Williams, M. E., Westermann, C. D., and Swerdlow, S. H. (1990) Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76, 1387-1391.
171. Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., and Arnold, A. (1993) Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7, 241-245.
172. Li, J. Y., Gaillard, F., Moreau, A., et al. (1999) Detection of translocation t (11;14) (q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am. J. Pathol. 154, 1449-1452.
173. Vaandrager, J. W., Schuuring, E., Zwikstra, E., et al. (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88, 1177-1182.
174. De Boer, C. J., Van Krieken, J. H., Kluin-Nelemans, H. C., Kluin, P. M., and Schuuring, E. (1995) Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10, 1833-1840.
175. Campo, E., Raffeld, M., and Jaffe, E. S. (1999) Mantle-cell lymphoma. Semin. Hematol. 36, 115-127.
176. Ott, G., Kalla, J., Hanke, A., et al. (1998) The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leukemia Lymphoma 32, 55-63.
177. Fang, N. Y., Greiner, T. C., Weisenburger, D. D., et al. (2003) Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc. Natl. Acad. Sci. USA 100, 5372-5377.
178. Woroniecka, R., Pienkowska-Grela, B., Grygalewicz, B., et al. (2002) Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL). J. Appl. Genet. 43, 545-453.
179. Weiss, L. M., Warnke, R. A., Sklar, J., and Cleary, M. L. (1987) Molecular analysis of the t (14;18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med. 317, 1185-1189.
180. Lipford, E., Wright, J. J., Urba, W., et al. (1987) Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70, 1816-1823.
181. Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M., and Frizzera, G. (1989) bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N. Engl. J. Med. 320, 1047-1054.
182. Peters, K., Zettl, A., Starostik, P., et al. (2000) Genetic imbalances in primary gastric diffuse large B-cell lymphomas: comparison of comparative genomic hybridization, microsatellite, and cytogenetic analysis. Diagn. Mol. Pathol. 9, 58-65.
183. Wilson, W. H., Teruya-Feldstein, J., Fest, T., et al. (1997) Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 89, 601-609.
184. Offit, K., Lo Coco, F., Louie, D. C., et al. (1994) Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N. Engl. J. Med. 331, 74-80.
185. Harris, N. L., Jaffe, E. S., Stein, H., et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361-1392.
186. Hui, P. K., Feller, A. C., and Lennert, K. (1988) High-grade non-Hodgkin's lymphoma of B-cell type. I. Histopathology. Histopathology 12, 127-143.
187. Wright, D. H. (1971) Burkitt's lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol. Annu. 6, 337-363.
188. Wright, D. H. (1997). What is Burkitt's lymphoma? J. Pathol. 182, 125-127.
189. Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K., and Kuppers, R. (1995) Burkitt's lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes. Mol. Med. 1, 495-505.
190. Tamaru, J., Hummel, M., Marafioti, T., et al. (1995) Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am. J. Pathol. 147, 1398-1407.
191. Gaidano, G., Ballerini, P., Gong, J. Z., et al. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 88, 5413-5417.
192. Gutierrez, M. I., Bhatia, K., Barriga, F., et al. (1992) Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 79, 3261-3266.
193. Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., and Raffeld, M. (1993) Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene 8, 2741-2748.
194. Cairo, M. S., Sposto, R., Perkins, S. L., et al. (2003) Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br. J. Haematol. 120, 660-670.
195. Matutes, E., Brito-Babapulle, V., Swansbury, J., et al. (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78, 3269-3274.
196. Matutes, E., Crockard, A. D., O'Brien, M., and Catovsky, D. (1983). Ultrastructural cytochemistry of chronic T-cell leukaemias. A study with four acid hydrolases. Histochem. J. 15, 895-909.
197. Brito-Babapulle, V. and Catovsky, D. (1991) Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet. Cytogenet. 55, 1-9.
198. Maljaei, S. H., Brito-Babapulle, V., Hiorns, L. R., and Catovsky, D. (1998) Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 103, 110-116.
199. Virgilio, L., Narducci, M. G., Isobe, M., et al. (1994) Identification of the TCL1 gene involved in T-cell malignancies. Proc. Natl. Acad. Sci. USA 91, 12, 530-12, 534.
200. Pekarsky, Y., Hallas, C., Isobe, M., Russo, G., and Croce, C. M. (1999). Abnormalities at 14q32.1 in T-cell malignancies involve two oncogenes. Proc. Natl. Acad. Sci. USA 96, 2949-2951.
201. Herbert, G. B., Shi, B., and Gartenhaus, R. B. (2001) Expression and stabilization of the MCT-1 protein by DNA damaging agents. Oncogene 20, 6777-6783.
202. Stilgenbauer, S., Schaffner, C., Litterst, A., et al. (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Med. 3, 1155-1159.
203. Vorechovsky, I., Luo, L., Dyer, M. J., et al. (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature Genet. 17, 96-99.
204. Sorour, A., Brito-Babapulle, V., Smedley, D., Yuille, M., and Catovsky, D. (2000) Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12. Cancer Genet. Cytogenet. 121, 128-132.
205. Hetet, G., Dastot, H., Baens, M., et al. (2000) Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia. Hematol. J. 1, 42-47.
206. Imamura, N., Kusunoki, Y., Kawa-Ha, K., et al. (1990) Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br. J. Haematol. 75, 49-59.
207. Chan, J. K., Sin, V. C., Wong, K. F., et al. (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89, 4501-4513.
208. Chan, J. K. (1998) Natural killer cell neoplasms. Anat. Pathol. 3, 77-145.
209. Wong, K. F., Zhang, Y. M., and Chan, J. K. (1999) Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia-is there a consistent pattern? Leukemia Lymphoma 34, 241-250.
210. Siu, L. L., Chan, J. K., and Kwong, Y. L. (2002) Natural killer cell malignancies: clinicopathologic and molecular features. Histol. Histopathol. 17(2), 539-554.
211. Chan, J. K., Yip, T. T., Tsang, W. Y., et al. (1994) Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 18, 938-946.
212. Arber, D. A., Weiss, L. M., Albujar, P. F., Chen, Y. Y., and Jaffe, E. S. (1993) Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am. J. Surg. Pathol. 17, 392-399.
213. Elenitoba-Johnson, K. S., Zarate-Osorno, A., Meneses, A., et al. (1998) Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod. Pathol. 11, 754-761.
214. Siu, L. L., Wong, K. F., Chan, J. K., and Kwong, Y. L. (1999) Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. Am. J. Pathol. 155, 1419-1425.
215. Ko, Y. H., Choi, K. E., Han, J. H., Kim, J. M., and Ree, H. J. (2001) Comparative genomic hybridization study of nasaltype NK/T-cell lymphoma. Cytometry 46, 85-91.
216. Willemze, R., Kerl, H., Sterry, W., et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90, 354-371.
217. Pancake, B. A., Zucker-Franklin, D., and Coutavas, E. E. (1995) The cutaneous T-cell lymphoma, mycosis fungoides, is a human T-cell lymphotropic virus-associated disease. A study of 50 patients. J. Clin. Invest. 95, 547-554.
218. Ghosh, S. K., Abrams, J. T., Terunuma, H., Vonderheid, E. C., and De Freitas, E. (1994) Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood 84, 2663-2671.
219. Ralfkiaer, E. (1991) Malignant lymphomas of true histiocytic origin: a clinical, histological, immunophenotypic and genotyic study. J. Pathol. 160, 9-17.
220. Bergman, R. (1999) How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides? Am. J. Dermatopathol. 21, 498-502.
221. Navas, I. C., Ortiz-Romero, P. L., Villuendas, R., et al. (2000) p16 (INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am. J. Path. 156, 1565-1572.
222. Mao, X., Lillington, D., Scarisbrick, J. J., et al. (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br. J. Dermatol. 147, 464-475.
223. Karenko, L., Sarna, S., Kahkonen, M., and Ranki, A. (2003) Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br. J. Dermatol. 148, 55-64.
224. Siegert, W., Nerl, C., Agthe, A., et al. (1995) Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann. Oncol. 6, 659-664.
225. Weiss, L. M., Strickler, J. G., Dorfman, R. F., Horning, S J., Warnke, R. A., and Sklar, J. (1986) Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am. J. Pathol. 122, 392-397.
226. O'Connor, N. T., Crick, J. A., Wainscoat, J. S., et al. (1986) Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J. Clin. Pathol. 39, 1229-1232.
227. Feller, A. C., Griesser, H., Schilling, C. V., et al. (1988). Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am. J. Pathol. 133, 549-556.
228. Lipford, E., Smith, H. R., Pittaluga, S., Jaffe, E. S., Steinberg, A. D., and Cossman, J. (1987) Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J. Clin. Invest. 79, 637-642.
229. Kaneko, Y., Maseki, N., Sakurai, M., et al. (1988) Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" features. Blood 72, 413-421.
230. Schlegelberger, B., Zhang, Y., Weber-Matthiesen, K., and Grote, W. (1994) Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. Blood 84(8), 2640-2648.
231. López-Guillermo, A., Cid, J., Salar, A., et al. (1998) Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R. E. A. L. Classification. Ann. Oncol. 9, 849-855.
232. Benharroch, D., Meguerian-Bedoyan, Z., Lamant, L., et al. (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91, 2076-2084.
233. Stein, H., Mason, D. Y., Gerdes, J., et al. (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66, 848-858.
234. Brugiáeres, L., Deley, M. C., Pacquement, H., et al. (1998) CD30 (+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92, 3591-3598.
235. Foss, H. D., Anagnostopoulos, I., Araujo, I., et al. (1996) Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88, 4005-4011.
236. Mason, D. Y., Bastard, C., Rimokh, R., et al. (1990) CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 74, 161-168.
237. Lamant, L., Meggetto, F., Al Saati, T., et al. (1996) High incidence of the t (2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptasepolymerase chain reaction, and P-80 immunostaining. Blood 87, 284-291.
238. Falini, B., Bigerna, B., Fizzotti, M., et al. (1998) ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am. J. Pathol. 153, 875-886.
239. Pittaluga, S., Wiodarska, I., Pulford, K., et al. (1997) The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am. J. Pathol. 151, 343-351.
240. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., and Mariamáe, B. (1999) A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2) (q25;p23) translocation. Blood. 93, 3088-3095.
241. Mason, D. Y., Pulford, K. A., Bischof, D., et al. (1998) Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res. 58, 1057-1062.
242. Trinei, M., Lanfrancone, L., Campo, E., et al. (2000) A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. Cancer Res. 60, 793-798.
243. Mao, X., Orchard, G., Lillington, D. M., Russell-Jones, R., Young, B. D., and Whittaker, S. (2003). Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes Chromosome Cancer 37, 176-185.
244. Going, J. J. (2003) Epithelial carcinogenesis: challenging monoclonality. J. Pathol. 200, 1-3.
245. Poppema, S. (1980) The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J. Histochem. and Cytochem. 28, 788-791.
246. Stein, H., Hansmann, M. L., Lennert, K., Brandtzaeg, P., Gatter, K. C., and Mason, D. Y. (1986) Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am. J. Clin. Pathol. 86, 292-297.
247. Ponzoni, M., Arrigoni, G., Gould, V. E., et al. (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum. Pathol. 31, 220-226.
248. Stein, H., Marafioti, T., Foss, H. D., et al. (2001) Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97(2), 496-501.
249. Laumen, H., Nielsen, P. J., and Wirth, T. (2000) The BOB.1/OBF.1 co-activator is essential for octamer-dependent transcription in B-cells. Eur. J. Immunol. 30, 458-469.
250. Marafioti, T., Hummel, M., Anagnostopoulos, I., et al. (1997) Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B-cells. N. Engl. J. Med. 337, 453-458.
251. Braeuninger, A., Kèuppers, R., Strickler, J. G., Wacker, H. H., Rajewsky, K., and Hansmann, M. L. (1997). Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal centerderived tumor B-cells. Proc. Natl. Acad. Sci. USA 94, 9337-9342.
252. Ohno, T., Stribley, J. A., Wu, G., Hinrichs, S. H., Weisenburger, D. D., and Chan, W. C. (1997) Clonality in nodular lymphocyte-predominant Hodgkin's disease. N. Engl. J. Med. 337, 459-465.
253. Diehl, V., Sextro, M., Franklin, J., et al. (1999) Clinical presentation, course, and prognostic factors in lymphocytepredominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J. Clin. Oncol. 17, 776-783.
254. Stein, H., Diehl, V., Marafioti, T., Jox, A., Wolf, J., and Hummel, M. (1999) The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular biology in Hodgkins' disease. In Hodgkin's Disease (Armitage, M. P. and Diehl, V., eds.), Lippincott, Williams and Wilkins, Philadelphia.
255. Stein, H., Gerdes, J., Kirchner, H., Schaadt, M., and Diehl, V. (1981) Hodgkin and Sternberg-Reed cell antigen (s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease. Intl. J. Cancer 28, 425-429.
256. Stein, H., Uchánska-Ziegler, B., Gerdes, J., Ziegler, A., and Wernet, P. (1982) Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Intl. J. Cancer 29, 283-290.
257. Hsu, S. M. and Jaffe, E. S. (1984) Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am. J. Clin. Pathol. 82, 29-32.
258. Chittal, S. M., Caveriviáere, P., Schwarting, R., et al. (1988) Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Am. J. Surg. Pathol. 12, 9-21.
259. Marafioti, T., Hummel, M., Foss, H. D., et al. (2000) Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95, 1443-1450.
260. Kanzler, H., Kèuppers, R., Hansmann, M. L., and Rajewsky, K. (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B-cells. J. Exp. Med. 184, 1495-1505.
261. Taylor, A. M., Metcalfe, J. A., Thick, J., and Mak, Y. F. (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87, 423-438.
262. Schlegelberger, B., Weber-Matthiesen, K., Himmler, A., et al. (1994) Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia 8, 72-80.
263. Sarris, A., Jhanwar, S., and Cabanillas, F. (1999) Cytogenetics of Hodgkin's disease. In Hodgkin's Disease (Mauch, P., Armitage, J. O., and Diehl, V., eds.), Lippincott, Williams and Wilkins, Philadelphia.
264. Joos, S., Kèupper, M., Ohl, S., et al. (2000) Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 60, 549-552.
265. Gravel, S., Delsol, G., and Al Saati, T. (1998) Single-cell analysis of the t (14;18) (q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 91, 2866-2874.
266. Waggott, W., Delsol, G., Jarret, R. F., et al. (1997) NPM-ALK gene fusion and Hodgkin's disease. Blood 90, 1712-1713.
267. Knowles, D. M., Chamulak, G. A., Subar, M., et al. (1988) Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann. Intern. Med. 108, 744-753.
268. Raphael, M. M., Audouin, J., Lamine, M., et al. (1994) Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. Am. J. Clin. Pathol. 101, 773-782.
269. Walts, A. E., Shintaku, I. P., and Said, J. W. (1990) Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am. J. Clin. Pathol. 94, 170-175.
270. Delecluse, H. J., Hummel, M., Marafioti, T., Anagnostopoulos, I., and Stein, H. (1999) Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern. J. Pathol. 188, 133-138.
271. Beylot-Barry, M., Vergier, B., Masquelier, B., et al. (1999) The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am. J. Surg. Pathol. 23, 1208-1216.
272. Burke, A. P., Andriko, J. A., and Virmani, R. (2000) Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIV-positive man. Cardiovasc. Pathol. 9, 49-52.
273. Ballerini, P., Gaidano, G., Gong, J. Z., Tassi, V., Saglio, G., Knowles, D. M., and Dalla-Favera, R. (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81, 166-176.
274. Gaidano, G., Carbone, A., Pastore, C., et al. (1997) Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 89, 3755-3762.
275. Gaidano, G., Lo Coco, F., Ye, B. H., et al. (1994) Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 84, 397-402.
276. Derringer, G. A., Thompson, L. D., Frommelt, R. A., Bijwaard, K. E., Heffess, C. S., and Abbondanzo, S. L. (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am. J. Surg. Pathol. 24, 623-639.
277. Longley, B. J. and Metcalfe, D. D. (2000). A proposed classification of mastocytosis incorporating molecular genetics. Hematol./Oncol. Clin. North Am. 14, vii, 697-701.
278. Longley, B. J., Tyrrell, L., Lu, S Z., et al. (1996) Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genet. 12, 312-314.
279. Longley, B. J., Jr., Metcalfe, D. D., Tharp, M., et al. (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc. Natl. Aca. Sci. USA 96(4), 1609-1614.
280. Lishner, M., Confino-Cohen, R., Mekori, Y. A., et al. (1996) Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J. Allergy Clin. Immunol. 98, 199-204.
281. Swolin, B., Rèodjer, S., Ogèard, I., and Roupe, G. (2002). Trisomies 8 and 9 not detected with FISH in patients with mastocytosis. Am. J. Hematol. 70, 324-325.
282. Dewald, G. W. and Stupca, P. (2000) 154 Chromosome anomalies in hematologic malignancies. Leukemia Res. 24(6), 457-489.